Wed, January 4, 2023

Maury Raycroft Downgraded (VERA) to Hold and Decreased Target to $6 on, Jan 4th, 2023

Maury Raycroft of Jefferies, Downgraded "Vera Therapeutics, Inc." (VERA) to Hold and Decreased Target from $32 to $6 on, Jan 4th, 2023.

Maury has made no other calls on VERA in the last 4 months.



There is 1 other peer that has a rating on VERA. Out of the 1 peers that are also analyzing VERA, 0 agree with Maury's Rating of Hold.



This is the rating of the analyst that currently disagrees with Maury


  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $38 on, Friday, November 18th, 2022